name | lhz |
sex | female
|
age | 85 岁 |
hospital number | 17018975 |
height | 155 cm |
weight | 50 kg |
BSA | 1.47 m2 |
APACHEⅡ | 16 分 |
Infection source | other
|
date | 2017/6/17 年/月/日 |
Sequential Organ Failure Assessment | 7 分 |
Fluid resuscitation | CVP8-12 mmHg
/MAP≥65 mmHg
/ScvO2≥70%
/urine volume≥0.5
|
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | trachea cannula
|
Early fluid resuscitation | yes
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
亚胺培南西司他丁 |
|
vasoactive agent | norepinephrine
/dopamine
|
30 min |
|
60 min |
|
60 min |
Temperature | 37.1 ℃ |
Heart Rate | 93 次/分 |
Breath | 30 次/分 |
Systolic pressure (SP) | 134 mmHg |
Diastolic pressure | 63 mmHg |
mean arterial pressure | 93 mmHg |
Pcv-aCO2 | 7 mmHg |
DO2 | 755.55 |
VO2 | 192.54 |
Ca-vO2 | 33.90 |
pH value | 7.38 |
PaO2 | 64 mmHg |
PaCO2 | 33 mmHg |
BE | -5.3 mmol/L(±2.3mmol/L) |
SaO2 | 91.30 % |
Blood lactic acid concentration, LAC | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 128.00 mmHg |
pH value | 7.34 |
PcvO2 | 4 mmHg |
PcvCO2 | 40 mmHg |
BE | -5.6 mmol/L |
ScvO2 | 68.00 % |
Volume of input | 900 ml |
Volume of output | 700 ml |
Volume of urine | 700 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.07 μg/Kg/min |
dopamine | yes
|
Dopamine Dosage | 5 μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
CVP | 13 mmHg |
cardiac output | 5.71 L/min |
cardiac index | 3.89 L/min/m2 |
stroke volume | 63 ml |
Stroke Index | 41 ml/m2 |
ITBVI | 1161 ml/m2 |
GEDVI | 929 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.1 |
SVRI | 1951 DSm2/cm5 |
CFI | 4.2 |
GEF | 18.00 % |
SVV | 12.00 % |
PPV | 8 % |
dPmax | 1276 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 27.5 mm |
IVC(expiratory phase) | 19 mm |
respiratory variations of inferior vena cavae diameter | 36.56 % |
mm |
|
mm |
|
mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 27.5 mm |
IVC(expiratory phase) | 19.4 mm |
Respiratory variations of inferior vena cavae diameter | 34.54 % |
mm |
|
mm |
|
mm |
|
mm |
Temperature | 36.6 ℃ |
Heart Rate | 82 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 132 mmHg |
Diastolic Pressure | 78 mmHg |
Mean Arterial Pressure | 110 mmHg |
Pcv-aCO2 | 4.00 mmHg |
DO2 | 717.95 |
VO2 | 194.06 |
Ca-vO2 | 34.96 |
PH value | 7.38 |
PaO2 | 85 mmHg |
PaCO2 | 34 mmHg |
BE | -4.9 mmol/L |
SaO2 | 96.00 % |
Blood Lactic Acid Concentration | 1.1 mmol/L |
Oxygenation index (PaO2/FiO2) | 212.5 mmHg |
PH value | 7.35 |
PcvO2 | 45 mmHg |
PcvCO2 | 38 mmHg |
BE | -5 mmol/L |
ScvO2 | 70.00 % |
Volume of input | 1617 ml |
Volume of output | 800 ml |
Volume of urine | 800 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 0.92 mg |
Dopamine Dosage | 30 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 5.57 L/min |
cardiac index | 3.8 L/min/m2 |
stroke volume | 68 ml |
Stroke Index | 47 ml/m2 |
ITBVI | 1210 ml/m2 |
GEDVI | 968 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.2 |
SVRI | 2289 DSm2/cm5 |
CFI | 4 |
GEF | 18.00 % |
SVV | 3.00 % |
PPV | 2 % |
dPmax | 1429 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.9 ℃ |
Heart Rate | 76 次/分 |
Breath | 17 次/分 |
Systolic Pressure | 146 mmHg |
Diastolic Pressure | 72 mmHg |
Mean Arterial Pressure | 101 mmHg |
Pcv-aCO2 | 3.00 mmHg |
DO2 | 693.41 |
VO2 | 173.77 |
Ca-vO2 | 31.36 |
PH value | 7.42 |
PaO2 | 74 mmHg |
PaCO2 | 33 mmHg |
BE | -3.5 mmol/L |
SaO2 | 94.80 % |
Blood Lactic Acid Concentration | 1.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 185.00 mmHg |
PH value | 7.4 |
PcvO2 | 40 mmHg |
PcvCO2 | 36 mmHg |
BE | -3.7 mmol/L |
ScvO2 | 71.00 % |
Volume of input | 1717 ml |
Volume of output | 1485 ml |
Volume of urine | 1200 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 0.92 mg |
Dopamine Dosage | 30 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 7 mmHg |
cardiac output | 5.56 L/min |
cardiac index | 3.79 L/min/m2 |
stroke volume | 70 ml |
Stroke Index | 48 ml/m2 |
ITBVI | 1155 ml/m2 |
GEDVI | 924 ml/m2 |
EVLWI | 9 ml/kg |
PVPI | 1.2 |
SVRI | 2159 DSm2/cm5 |
CFI | 4.1 |
GEF | 20.00 % |
SVV | 3.00 % |
PPV | 3 % |
dPmax | 1248 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 27.4 mm |
IVC(expiratory phase) | 19.5 mm |
Respiratory variations of inferior vena cavae diameter | 33.69 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 98 次/分 |
Breath | 22 次/分 |
Systolic Pressure | 141 mmHg |
Diastolic Pressure | 68 mmHg |
Mean Arterial Pressure | 98 mmHg |
Pcv-aCO2 | 1.00 mmHg |
DO2 | 706.54 |
VO2 | 142.07 |
Ca-vO2 | 23.94 |
PH value | 7.37 |
PaO2 | 108 mmHg |
PaCO2 | 18 mmHg |
BE | -14.1 mmol/L |
SaO2 | 97.70 % |
Blood Lactic Acid Concentration | 1.3 mmol/L |
Oxygenation index (PaO2/FiO2) | 270.00 mmHg |
PH value | 7.38 |
PcvO2 | 49 mmHg |
PcvCO2 | 19 mmHg |
BE | -14 mmol/L |
ScvO2 | 78.00 % |
Volume of input | 3684 ml |
Volume of output | 2250 ml |
Volume of urine | 1800 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 0.92 mg |
Dopamine Dosage | 30 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 9 mmHg |
cardiac output | 5.98 L/min |
cardiac index | 4.08 L/min/m2 |
stroke volume | 71 ml |
Stroke Index | 48 ml/m2 |
ITBVI | 1138 ml/m2 |
GEDVI | 910 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.1 |
SVRI | 1760 DSm2/cm5 |
CFI | 4.5 |
GEF | 21.00 % |
SVV | 3.00 % |
PPV | 3 % |
dPmax | 1073 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 27.5 mm |
IVC(expiratory phase) | 19.8 mm |
Respiratory variations of inferior vena cavae diameter | 32.56 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 86 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 143 mmHg |
Diastolic Pressure | 65 mmHg |
Mean Arterial Pressure | 91 mmHg |
Pcv-aCO2 | 5.00 mmHg |
DO2 | 759.82 |
VO2 | 155.73 |
Ca-vO2 | 26.78 |
PH value | 7.43 |
PaO2 | 87 mmHg |
PaCO2 | 33 mmHg |
BE | -2.2 mmol/L |
SaO2 | 96.9 % |
Blood Lactic Acid Concentration | 2.5 mmol/L |
Oxygenation index (PaO2/FiO2) | 263.64 mmHg |
PH value | 7.4 |
PcvO2 | 48 mmHg |
PcvCO2 | 38 mmHg |
BE | -2.3 mmol/L |
ScvO2 | 77.00 % |
Volume of input | 6373 ml |
Volume of output | 3840 ml |
Volume of urine | 3050 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 0.92 mg |
Dopamine Dosage | 30 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 5.84 L/min |
cardiac index | 3.98 L/min/m2 |
stroke volume | 69 ml |
Stroke Index | 49 ml/m2 |
ITBVI | 1145 ml/m2 |
GEDVI | 920 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.1 |
SVRI | 1860 DSm2/cm5 |
CFI | 4.3 |
GEF | 21.00 % |
SVV | 4.00 % |
PPV | 3 % |
dPmax | 1123 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 27.4 mm |
IVC(expiratory phase) | 19.5 mm |
Respiratory variations of inferior vena cavae diameter | 33.69 % |
mm |
|
mm |
|
mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.5 ℃ |
Heart Rate | 91 次/分 |
Breath | 19 次/分 |
Systolic Pressure | 138 mmHg |
Diastolic Pressure | 69 mmHg |
Mean Arterial Pressure | 92 mmHg |
Pcv-aCO2 | 2.00 mmHg |
DO2 | 791.92 |
VO2 | 138.51 |
Ca-vO2 | 24.74 |
PH value | 7.46 |
PaO2 | 94 mmHg |
PaCO2 | 34 mmHg |
BE | -0.1 mmol/L |
SaO2 | 97.00 % |
Blood Lactic Acid Concentration | 1.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 284.85 mmHg |
PH value | 7.45 |
PcvO2 | 49 mmHg |
PcvCO2 | 36 mmHg |
BE | -0.1 mmol/L |
ScvO2 | 80.00 % |
Volume of input | 8873 ml |
Volume of output | 5640 ml |
Volume of urine | 4650 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 0.92 mg |
Dopamine Dosage | 30 mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 5.63 L/min |
cardiac index | 3.87 L/min/m2 |
stroke volume | 70 ml |
Stroke Index | 48 ml/m2 |
ITBVI | 1089 ml/m2 |
GEDVI | 860 ml/m2 |
EVLWI | 8 ml/kg |
PVPI | 1.2 |
SVRI | 1753 DSm2/cm5 |
CFI | 4.4 |
GEF | 22.00 % |
SVV | 4.00 % |
PPV | 3 % |
dPmax | 1208 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 0 条 |
LUS | 0 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 27.2 mm |
Respiratory variations of inferior vena cavae diameter | 19.5 % |
IVC(inspiratory phase) | 32.98 mm |
mm |
|
mm |
|
mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 194 pg/ml |
cTNI | 0.225 ng/ml |
Creatine kinase isoenzyme, CKMB | 2.7 U/L |
Creatinine | 51 umol/L |
Urea nitrogen | 7 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 17.3 X10*9/L |
neutrophilic granulocyte percentage | 95.4 % |
Hb | g/L |
CRP | 129 mg/L |
Procalcitonin, PCT | 1.6 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 7 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 697 pg/ml |
cTNI | 1.79 ng/ml |
Creatine kinase isoenzyme, CKMB | 5.4 U/L |
Creatinine | 42 umol/L |
Urea nitrogen | 7.5 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 9.4 X10*9/L |
neutrophilic granulocyte percentage | 95.6 % |
Hb | g/L |
CRP | 126 mg/L |
Procalcitonin, PCT | 1.32 ng/ml |
Sequential Organ Failure Assessment | 2 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 914 pg/ml |
cTNI | 1.12 ng/ml |
Creatine kinase isoenzyme, CKMB | 2.7 U/L |
Creatinine | 40 umol/L |
Urea nitrogen | 9.6 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 8.2 X10*9/L |
neutrophilic granulocyte percentage | 94.6 % |
Hb | g/L |
CRP | 101 mg/L |
Procalcitonin, PCT | 1.4 ng/ml |
Sequential Organ Failure Assessment | 2 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 10 分 |
Complication | no
|
prognosis | discharge
|
28-day mortality | no
|
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 24 天 |
duration in ICU | 4 天 |
duration of mechanical ventilation | 48 小时 |
ICU expenses | 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |